Literature DB >> 11512522

Apoptosis is critical for drug response in vivo.

C A Schmitt1, S W Lowe.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11512522     DOI： 10.1054/drup.2001.0188

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN： 1368-7646            Impact factor:   18.500


× No keyword cloud information.
  16 in total

1.  The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.

Authors:  Harriet M Kluger; Mary M McCarthy; Ayesha B Alvero; Mario Sznol; Stephan Ariyan; Robert L Camp; David L Rimm; Gil Mor
Journal:  J Transl Med       Date:  2007-01-26       Impact factor: 5.531

2.  Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer.

Authors:  Li Pan; Xing-Chen Peng; Fei Leng; Qing-Zhong Yuan; Yan Shan; Dan-Dan Yu; Zhi-Yong Li; Xiang Chen; Wen-Jing Xiao; Yuan Wen; Tian-Tai Ma; Li Yang; Yong-Qiu Mao; Han-Shuo Yang; Yu-Quan Wei; Chun-Ting Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-09       Impact factor: 4.553

Review 3.  HtrA serine proteases as potential therapeutic targets in cancer.

Authors:  Jeremy Chien; Mara Campioni; Viji Shridhar; Alfonso Baldi
Journal:  Curr Cancer Drug Targets       Date:  2009-06       Impact factor: 3.428

4.  The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy.

Authors:  Olga A Patutina; Nadezda L Mironova; Nelly A Popova; Vasily I Kaledin; Valery P Nikolin; Valentin V Vlassov; Marina A Zenkova
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

5.  In vitro and in vivo growth inhibition of drug-resistant ovarian carcinoma cells using a combination of cisplatin and a TRAIL-encoding retrovirus.

Authors:  Fang Li; Yi Guo; Lingfei Han; Yankang Duan; Fang Fang; Sumei Niu; Qiujie Ba; Huaishi Zhu; Fanfei Kong; Chao Lin; Xuejun Wen
Journal:  Oncol Lett       Date:  2012-09-20       Impact factor: 2.967

6.  Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions.

Authors:  Patrizia Marini; Dorothea Junginger; Stefan Stickl; Wilfried Budach; Maximilian Niyazi; Claus Belka
Journal:  Radiat Oncol       Date:  2009-10-27       Impact factor: 3.481

7.  Mir-375 enhances ruthenium-derived compound Rawq01 induced cell death in human ovarian cancer.

Authors:  Xiaowen Shao; Wenjie Mei; Wenhao Weng; Jinlong Qin; Jianhong Zhou; Jie Liu; Jiajing Cheng
Journal:  Int J Clin Exp Pathol       Date:  2013-05-15

8.  Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer.

Authors:  Sven Rottenberg; Anders O H Nygren; Marina Pajic; Fijs W B van Leeuwen; Ingrid van der Heijden; Koen van de Wetering; Xiaoling Liu; Karin E de Visser; Kenneth G Gilhuijs; Olaf van Tellingen; Jan P Schouten; Jos Jonkers; Piet Borst
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-11       Impact factor: 11.205

9.  Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance.

Authors:  Janine T Erler; Christopher J Cawthorne; Kaye J Williams; Marianne Koritzinsky; Bradley G Wouters; Clare Wilson; Crispin Miller; Costas Demonacos; Ian J Stratford; Caroline Dive
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic Pathway.

Authors:  Andrew J Crowther; Jennifer K Ocasio; Fang Fang; Jessica Meidinger; Jaclyn Wu; Allison M Deal; Sha X Chang; Hong Yuan; Ralf Schmid; Ian Davis; Timothy R Gershon
Journal:  Cancer Res       Date:  2016-04-13       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.